Table of Contents
- 1 What is Quintiles called now?
- 2 Who did Quintiles merge with?
- 3 Is Quintiles now IQVIA?
- 4 Is IQVIA and Quintiles same?
- 5 Who bought Quintiles?
- 6 Who are IQVIA’s customers?
- 7 Who are IQVIA clients?
- 8 Who bought IQVIA?
- 9 How much does the CEO of IQVIA make?
- 10 Is Covance a subsidiary of labcorp?
- 11 Is IMS Health now IQVIA?
- 12 When was Quintiles started?
- 13 What does quintiles do for pharmaceutical companies?
- 14 Who is the CEO of Quintiles?
- 15 Why did Quintiles and IMS Health come together?
- 16 What happened to quintiles healthcare in 2016?
What is Quintiles called now?
Quintiles – which became QuintilesIMS last year in the wake of a $17.6 billion merger – is now called IQVIA, and it has swapped its trademark red logo for a more subdued blue acronym this month.
Who did Quintiles merge with?
 Reuters, “Quintiles is merging with IMS in a deal worth about $9 billion,” (5/3/2016).  Rebecca Clifford, “IMS Health and Quintiles complete merger,” PMLive (10/4/2016).
Is Quintiles now IQVIA?
A year after its trailblazing merger, QuintilesIMS, the world’s largest clinical outsourcing firm will now be known as IQVIA, the company announced today.
Is IQVIA and Quintiles same?
QuintilesIMS has changed its name to IQVIA to reflect its October 2016 merger with IMS Health. IMS Health and Quintiles came together because our clients were asking for better, faster ways to bring innovations to patients and capture the improvements the industry has been pursuing for years.
Who bought Quintiles?
IMS Health Holdings Inc.
IMS Health Holdings Inc. will buy Quintiles Transnational Holdings Inc. in an all-stock transaction for about $9 billion, bringing together two of the biggest providers of data and services for the pharmaceutical industry.
Who are IQVIA’s customers?
Customers now include AstraZeneca, Novo Nordisk, Roche, Adhera Therapeutics, Napo Pharmaceuticals, Pierre Fabre Pharmaceuticals, PruGen Pharmaceuticals, Recordati, Theramex and Zentiva.
Who are IQVIA clients?
Who bought IQVIA?
2016: Over the course of 2016, concluding on October 3, Quintiles underwent a $17.6 billion merger with IMS Health, becoming QuintilesIMS.
How much does the CEO of IQVIA make?
Compensation by Company
|Name And Title||Total Compensation|
|Ari Bousbib Chairman and Chief Executive Officer||Total Compensation $24,677,162 View details|
|Eric M. Sherbet Executive Vice President, General Counsel and Secretary||Total Compensation $2,827,534 View details|
Is Covance a subsidiary of labcorp?
Labcorp Drug Development as Covance 2014-Present was listed as a Labcorp subsidiary. On August 31, 2017, Labcorp acquired global life sciences business, Chiltern, as part of its drug development services with Covance.
Is IMS Health now IQVIA?
IMS Health was headquartered in Danbury, Connecticut. Over 2016 Quintiles and IMS Health merged, and the resulting company was named QuintilesIMS, which was renamed to IQVIA in 2017.
When was Quintiles started?
February 1982, North Carolina
What does quintiles do for pharmaceutical companies?
With offices in 60 countries, Quintiles provides product development, financial assistance and commercial services to assist pharmaceutical companies in their clinical trials. Founder Dennis Gillings stepped down as CEO in 2012 but remains executive chairman of the company’s board of directors.”
Who is the CEO of Quintiles?
Founder Dennis Gillings stepped down as CEO in 2012 but remains executive chairman of the company’s board of directors.” Quintiles was founded in 1982 by Dennis Gillings, Ph.D., CBE, then a professor of biostatistics at the University of North Carolina, Chapel Hill.
Why did Quintiles and IMS Health come together?
In 2016, Quintiles and IMS Health came together to create something entirely new. IQVIA brings together advances in data science, technology, and human science expertise to help the healthcare industry make better decisions, and ultimately to improve patient outcomes.
What happened to quintiles healthcare in 2016?
2016: Over the course of 2016, concluding on October 3, Quintiles underwent a $17.6 billion merger with IMS Health, becoming QuintilesIMS. As a result of the merger, the OneKey worldwide healthcare professionals database developed by Cegedim Relationship Management became part of QuintilesIMS.